Imperial College London
Professor Peter Openshaw is a respiratory physician and immunologist, expert in immunopathogenesis and defence against RSV and influenza, in mice and in humans. He led a large national consortium (‘MOSAIC’) to investigate the pathogenesis of severe influenza in the 2009-10, identifying novel inflammatory patterns and the effects of host and pathogen variation. He is vice-Chair or NERVTAG, a Department of Health committee horizon-scanning for emerging respiratory threats; he directs studies of human volunteers experimentally infected with RSV and influenza and directs HIC-Vac, an international consortium that promotes the use of human challenge to accelerate vaccine development. He has authored >300 publications with 14,644 citations (h-index 62).